Ebola and ethics: autopsy of a failure
- 23 April 2015
- Vol. 350 (apr23 10), h2105
- https://doi.org/10.1136/bmj.h2105
Abstract
Thousands died while we argued over the wrong questions The current epidemic of Ebola virus disease has attracted medical ethics commentators like bees to a honey pot. No previous infectious disease epidemic has elicited such a flurry of articles on the ethical challenges associated with infection control and treatment in such a short time. Has this been of any use? The ethical questions raised by various authors broadly fall into three categories. The first relates to questions of individual medical ethics, in particular surrounding the compassionate use of experimental drugs and vaccines. The second concerns allocation of resources to these experimental treatments versus infection control. And the third centres on how resources should be spent in the long term—on building a public health and clinical infrastructure that can cope in an epidemic instead of propping up a weak infrastructure during a humanitarian crisis. The tension between these moral challenges can be grouped along two axes: individual versus public health, and short term versus long term (figure⇓). Tension between moral challenges and possible responses to the Ebola virus epidemic The short term use of experimental drugs such as ZMapp, first used in a few repatriated health workers from high income countries, attracted far …This publication has 6 references indexed in Scilit:
- Ebola: what it tells us about medical ethicsJournal of Medical Ethics, 2014
- Ethical considerations of experimental interventions in the Ebola outbreakThe Lancet, 2014
- Ebola: learn from the pastNature, 2014
- Ebola: towards an International Health Systems FundThe Lancet, 2014
- Ebola: a failure of international collective actionThe Lancet, 2014
- Ethical issues in funding research and development of drugs for neglected tropical diseasesJournal of Medical Ethics, 2009